Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores - PMC

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. The Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) score is commonly used, although the utility regarding this score in staging dementia severity is not well established. To investigate the effectiveness of CDRSOB scores in staging dementia severity compared with the global CDR score. Retrospective study. Texas Alzheimer's Research Consortium minimum data set cohort. A total of 1577 participants (110 controls, 202 patients with mild cognitive impairment, and 1265 patients with probable Alzheimer disease) were available for analysis. Receiver

Arch Neurol . Author manuscript; available in PMC: 2012 Aug 1. Published in final edited form as: Arch Neurol. 2008 Aug;65(8):1091–1095. doi: 10.1001/archneur.65.8.1091 Staging Dementia Using Clinical Dementia Rating Scale Sum of Boxes Scores A Texas Alzheimer's Research Consortium Study Sid E O'Bryant Sid E O'Bryant , PhD 1 Department of Neuropsychiatry and Behavioral Science, Texas Tech University Health Sciences Center, Lubbock (Dr O'Bryant); Division of Epidemiology, University of Texas Health Science Center (Dr Waring and Mr Lupo); Departments of Psychiatry (Drs Cullum and Lacritz) and Ne

saved by

• Jess Rouet

related reading

• Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review - PMCncbi.nlm.nih.gov
• The amyloid hypothesis in Alzheimer disease: new insights from new therapeuticsnature.com
• Gap Mapgap-map.org
• Accuracy of the Early Diagnosis of Parkinson’s Diseasepmc.ncbi.nlm.nih.gov
• Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study - PMCpmc.ncbi.nlm.nih.gov
• Using Interpretability to Identify a Novel Class of Alzheimer's Biomarkersgoodfire.ai
• Brain Imaging in Differential Diagnosis of Dementiapracticalneurology.com
• Prediction of Parkinson’s Disease Using Machine Learning Methodsncbi.nlm.nih.gov
• Parkinson’s Disease Diagnostic Observations (PADDO): study rationale and design of a prospective cohort study for early differentiation of parkinsonismpmc.ncbi.nlm.nih.gov
• Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status - PMCncbi.nlm.nih.gov
• Prognostic Modeling of Parkinson’s Disease Progression Using Early Longitudinal Patterns of Changepmc.ncbi.nlm.nih.gov
• A comprehensive review of machine learning algorithms and their application in geriatric medicine: present and future - PMCncbi.nlm.nih.gov